Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ADJUPROBE

Financiado

Cerrado

LEAD ADJUVANT PROBE AS A DUAL TECHNOLOGICAL TOOL TO ADVANCE NEXT-GENERATION VACC...

LEAD ADJUVANT PROBE AS A DUAL TECHNOLOGICAL TOOL TO ADVANCE NEXT-GENERATION VACCINE DEVELOPMENT The goal of ADJUPROBE is to build upon a major discovery made within the ERC-2016-STG-716878 project to validate and valorise our dual synthetic technological tool, moving it forward to boost vaccine efficacy from technical develo... ver más

28/02/2026

ASOCIACION CENTRO...

150K€

Presupuesto del proyecto: 150K€

Líder del proyecto

ASOCIACION CENTRO DE INVESTIGACION COOPERATIV... Actividades de organizaciones profesionales asociacion

TRL 4-5 | 50K€

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-11-15

ERC-2023-POC: ERC PROOF OF CONCEPT GRANTS Objective:Objectives:The ERC Proof of Concept Grants aim at facilitating exploration of the commerci...

I+D

Cerrada hace 2 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

ASOCIACION CENTRO DE INVESTI...

150.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

ADJUVACCINE Development of a marketable adjuvant candidate for vaccine a... 150K€ Cerrado

ADJUV-ANT VACCINES Elucidating the Molecular Mechanisms of Synthetic Saponin Ad... 1M€ Cerrado

ADJU-PLATFORM MINIMAL SAPONIN-BASED ADJUVANT VACCINE PLATFORM 150K€ Cerrado

QS21-Mech Target identification and elucidation of the molecular mecha... 173K€ Cerrado

PHARVAT Platform for the Harmonization of Vaccine Adjuvant Testing 334K€ Cerrado

TRANSVAC European Network of Vaccine Development and Research 12M€ Cerrado

Duración del proyecto: 27 meses Fecha Inicio: 2023-11-15
Fecha Fin: 2026-02-28

Líder del proyecto

ASOCIACION CENTRO DE INVESTIGACION COOPERATIV... Actividades de organizaciones profesionales asociacion

TRL 4-5 | 50K€

Presupuesto del proyecto 150K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The goal of ADJUPROBE is to build upon a major discovery made within the ERC-2016-STG-716878 project to validate and valorise our dual synthetic technological tool, moving it forward to boost vaccine efficacy from technical development to commercialisation. We will exploit our lead adjuvant in further preclinical settings in terms of scaled-up production, functional validation, and additional vaccine trials in mice with clinically relevant antigens. In parallel, we will confirm and advance the innovation of our technology towards commercial exploitation by implementing a multifaceted valorisation plan supporting the technical development. The plan includes consolidation of intellectual property (IP) rights and IP position, engagement of pharma/biotech partners and investors, as well as verification of the potential of spin-off creation. Our adjuvant technology based on a scalable semi-synthetic saponin has demonstrated its potential as a dual tool with superior performance to the approved, natural QS-21 adjuvant. These breakthroughs have been provisionally protected via a priority patent application and have also attracted the interest of important biotech/pharma companies. ADJUPROBE will provide decisive proof-of-concept for preclinical development and validation of our technological tool, including synthesis upscaling and confirmation of the superiority of our adjuvant lead in disease-related vaccines benchmarked against QS-21. Moreover, key valorisation outcomes based on successful implementation of our transference and commercialisation plan, such as advancing IPR protection and spin-off creation together with fruitful pharma and investor partnerships, will facilitate market entry and traction for ADJUPROBE in the near future.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores